日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure.

首创的 MKK4 抑制剂可增强肝脏再生并预防肝衰竭

Zwirner Stefan, Abu Rmilah Anan A, Klotz Sabrina, Pfaffenroth Bent, Kloevekorn Philip, Moschopoulou Athina A, Schuette Svenja, Haag Mathias, Selig Roland, Li Kewei, Zhou Wei, Nelson Erek, Poso Antti, Chen Harvey, Amiot Bruce, Jia Yao, Minshew Anna, Michalak Gregory, Cui Wei, Rist Elke, Longerich Thomas, Jung Birgit, Felgendreff Philipp, Trompak Omelyan, Premsrirut Prem K, Gries Katharina, Muerdter Thomas E, Heinkele Georg, Wuestefeld Torsten, Shapiro David, Weissbach Markus, Koenigsrainer Alfred, Sipos Bence, Ab Eiso, Zacarias Magdalena Ortiz, Theisgen Stephan, Gruenheit Nicole, Biskup Saskia, Schwab Matthias, Albrecht Wolfgang, Laufer Stefan, Nyberg Scott, Zender Lars

Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis

上皮钠通道抑制剂BI 1265162治疗囊性纤维化的临床前评价

Nickolaus, Peter; Jung, Birgit; Sabater, Juan; Constant, Samuel; Gupta, Abhya

BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis

BAL细胞基因表达可指示特发性肺纤维化的预后和气道基底细胞参与情况

Prasse, Antje; Binder, Harald; Schupp, Jonas C; Kayser, Gian; Bargagli, Elena; Jaeger, Benedikt; Hess, Moritz; Rittinghausen, Susanne; Vuga, Louis; Lynn, Heather; Violette, Shelia; Jung, Birgit; Quast, Karsten; Vanaudenaerde, Bart; Xu, Yan; Hohlfeld, Jens M; Krug, Norbert; Herazo-Maya, Jose D; Rottoli, Paola; Wuyts, Wim A; Kaminski, Naftali